Mexedia Shareholders Approve Capital Increase of Up to EUR 20 Million Reserved for Likan AG

• Mexedia shareholders approved a capital increase of up to EUR 20 million reserved for Likan AG on October 28, 2026.
• Up to 20,000,000 ordinary shares at EUR 1 are authorized within 12 months of definitive agreements, no later than December 31, 2027.
• Directors were authorized to implement the increase; the initial EUR 1 million tranche is planned upon signing definitive agreements.
• Shareholders confirmed Sara Di Mario as a director.
• They also adopted charter amendments covering the capital increase, director replacements and the convening and conduct of governing-body meetings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mexedia S.p.A. Società Benefit published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.